Dr. Miele Cosmed Group S.A. (WSE:DMG)
Poland · Delayed Price · Currency is PLN 2.800
-0.030 (-1.06%)
At close: Jan 30, 2026
Dr. Miele Cosmed Group Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 501.04 | 488.35 | 444.48 | 396.57 | 351.87 | 364.81 | |
Revenue Growth (YoY) | 3.72% | 9.87% | 12.08% | 12.70% | -3.55% | 17.73% |
Cost of Revenue | 291.88 | 278.9 | 272.98 | 271.8 | 218.41 | 203.5 |
Gross Profit | 209.16 | 209.45 | 171.5 | 124.77 | 133.46 | 161.31 |
Selling, General & Admin | 131.76 | 124.98 | 105.06 | 94.46 | 94.93 | 84.98 |
Other Operating Expenses | 28.16 | 23.56 | 21.59 | 17.81 | 12.71 | 34.09 |
Operating Expenses | 173.91 | 161.1 | 138.61 | 123.6 | 118.28 | 129.99 |
Operating Income | 35.25 | 48.36 | 32.89 | 1.17 | 15.17 | 31.33 |
Interest Expense | -5.23 | -5.12 | -4.69 | -3.72 | -1.37 | -2.41 |
Interest & Investment Income | 0.33 | 0.28 | 0.12 | 0.18 | 0.12 | 0.18 |
Currency Exchange Gain (Loss) | -0.28 | -0.28 | -1.24 | 0.21 | -0.33 | 1.85 |
Other Non Operating Income (Expenses) | -0.14 | -0.14 | -0.04 | -0.08 | -0.21 | -0.26 |
EBT Excluding Unusual Items | 29.93 | 43.1 | 27.04 | -2.24 | 13.38 | 30.69 |
Gain (Loss) on Sale of Assets | 0.47 | 0.47 | 0.16 | 0.37 | -0.12 | 0.62 |
Asset Writedown | -0.21 | -0.21 | - | -0.23 | - | - |
Pretax Income | 30.19 | 43.36 | 27.2 | -2.1 | 13.26 | 31.3 |
Income Tax Expense | 5.98 | 7.37 | 4.98 | 0.17 | 1.66 | 2.68 |
Earnings From Continuing Operations | 24.21 | 35.99 | 22.22 | -2.27 | 11.6 | 28.63 |
Net Income to Company | 24.21 | 35.99 | 22.22 | -2.27 | 11.6 | 28.63 |
Net Income | 24.21 | 35.99 | 22.22 | -2.27 | 11.6 | 28.63 |
Net Income to Common | 24.21 | 35.99 | 22.22 | -2.27 | 11.6 | 28.63 |
Net Income Growth | -32.66% | 61.97% | - | - | -59.49% | 755.78% |
Shares Outstanding (Basic) | 86 | 87 | 87 | 87 | 87 | 87 |
Shares Outstanding (Diluted) | 86 | 87 | 87 | 87 | 87 | 87 |
Shares Change (YoY) | -1.30% | - | - | - | - | - |
EPS (Basic) | 0.28 | 0.41 | 0.25 | -0.03 | 0.13 | 0.33 |
EPS (Diluted) | 0.28 | 0.41 | 0.25 | -0.03 | 0.13 | 0.33 |
EPS Growth | -29.96% | 64.00% | - | - | -60.34% | 755.79% |
Free Cash Flow | 14.94 | 19.14 | 21.56 | -0.75 | 8.36 | 17.42 |
Free Cash Flow Per Share | 0.17 | 0.22 | 0.25 | -0.01 | 0.10 | 0.20 |
Dividend Per Share | 0.100 | 0.100 | 0.090 | - | 0.030 | 0.060 |
Dividend Growth | 11.11% | 11.11% | - | - | -50.00% | - |
Gross Margin | 41.75% | 42.89% | 38.58% | 31.46% | 37.93% | 44.22% |
Operating Margin | 7.03% | 9.90% | 7.40% | 0.29% | 4.31% | 8.59% |
Profit Margin | 4.83% | 7.37% | 5.00% | -0.57% | 3.30% | 7.85% |
Free Cash Flow Margin | 2.98% | 3.92% | 4.85% | -0.19% | 2.38% | 4.78% |
EBITDA | 46.5 | 58.16 | 42.47 | 10.69 | 24.29 | 40.53 |
EBITDA Margin | 9.28% | 11.91% | 9.55% | 2.70% | 6.90% | 11.11% |
D&A For EBITDA | 11.25 | 9.81 | 9.58 | 9.52 | 9.12 | 9.2 |
EBIT | 35.25 | 48.36 | 32.89 | 1.17 | 15.17 | 31.33 |
EBIT Margin | 7.03% | 9.90% | 7.40% | 0.29% | 4.31% | 8.59% |
Effective Tax Rate | 19.81% | 16.99% | 18.30% | - | 12.52% | 8.55% |
Revenue as Reported | 12.69 | - | - | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.